PicomWeb is a light, zero-footprint, content delivery mechanism for diagnostic images and related documents is based on Adobe Flash technology. It allows interactive ECG waveforms viewing that are rendered on the fly. This allows clinicians to modify the speed and gain of the tracing for a more precise view of the ECG morphology, whether the user is investigating from a PC or a smart phone.
February 9, 2010 - The U.S. Food and Drug Administration says it is starting a program designed to reduce unnecessary medical radiation exposure that will focus on three types of imaging procedures: computed tomography (CT), nuclear medicine and fluoroscopy. The FDA considers those procedures the greatest contributors to total U.S.
February 9, 2010 – The FDA approved CRESTOR (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures in individuals without clinically evident coronary heart disease.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 9, 2010 – Researchers are developing technology that they hope will one day prevent thrombus formation on cardiovascular devices without the use of anticoagulation drugs.
February 9, 2010 – Off-pump bypass surgery, or “beating heart surgery,” was developed in hopes of creating a safer way to fix cholesterol-clogged coronary arteries.
February 9, 2010 – In response to increasing demand for its radio frequency identification (RFID) units in Europe, Terso Solutions Inc. has formed Terso GmbH in Mannheim, Germany.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The LifeDop 300 ABI from Summit Doppler Systems is an economical, hand-held ankle brachial index (ABI) system allows clinicians to perform the exam faster. The system has a keypad feature for easily entering pressure data and calculating the indices. It stores pressure data and two ankle waveforms prior to printing.
The Vista AVS from Summit Doppler Systems Inc. is a full-featured ankle brachial index (ABI)/vascular system using different modalities for obtaining systolic pressures and waveforms. Either a bi-directional Doppler probe or pulse volume recording (PVR) can be used to obtain ankle waveforms required for reimbursement.
At ACC 2010, Philips Healthcare will focus on the full spectrum of cardiology care – from diagnosis and treatment to disease management and home monitoring to enhance patient care.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Philips Healthcare's CT systems use the iDose application that enables clinicians to reduce X-ray radiation dose by up to 80 percent.
February 8, 2010 – Partnering with leading implantable cardioverter defibrillators (ICD) and pacemaker manufacturers, ScottCare Corp. has consolidated device information into one common platform with enhanced reporting and analysis capabilities. The newst addition to the CardioView Dx suite of diagnostic solutions is OneView, designed to manage all pacer and ICD patients and information.
McKesson’s Practice Partner is an award-winning electronic health record (EHR) and medical billing software solution for physician practices which improves efficiency, quality of care, and communication while reducing time spent on administrative tasks.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 8, 2010 – The FDA cleared the Sorin Paradym CRT Model 8750, a cardiac resynchronization therapy defibrillator (CRT-D), which features a new battery technology that delivers 37 joules, one of the highest energy levels of any implantable cardiac defibrillator (ICD).
February 5, 2010 – European CE mark approval was granted and first implants reported for the Fortify and Fortify ST implantable cardioverter defibrillators (ICD) and Unify cardiac resynchronization therapy defibrillator (CRT-D). The reduced size of these new devices compared to those of previous generations creates one of the smallest available device footprints in the industry.
February 5, 2010 – A new, large-scale pivotal phase III trial has been initiated for edoxaban to evaluate its safety and efficacy in reducing recurrent venous thromboembolic (VTE) complications in patients with deep-vein thrombosis (DVT) and/or pulmonary embolism (PE).
February 09, 2010
